Angiogenesis: Trabeculectomy and Bevacizumab

Author: Jue Andrea  

Publisher: Informa Healthcare

ISSN: 0882-0538

Source: Seminars in Ophthalmology, Vol.24, Iss.2, 2009-03, pp. : 122-125

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

The use of bevacizumab for the treatment of proliferative diabetic retinopathy, neovascular glaucoma, neovascular age related macular degeneration, and cystoid macular edema has been extensively reported upon. From the published case reports available, bevacizumab may be a useful adjunct to the trabeculectomy procedure.